Back to top

Tvardi Therapeutics (TVRD) Downgraded by Raymond James | TVRD Stock News

Tvardi Therapeutics (TVRD) Downgraded by Raymond James | TVRD Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tvardi Therapeutics, Inc. (TVRD)